Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
This study will examine the safety and tolerability, PK and PD of subcutaneously administered GSK1841157 in patients with RA on stable dose Methotrexate. The study comprises a single dose escalation/de-escalation phase to investigate the minimal efficacious dose based on PD markers with an acceptable safety profile.
Epistemonikos ID: 9d1156e308458870d95f83548daedec5437e9319
First added on: Mar 23, 2022